| Reference |
|---|
Yang Z, Jia X, Deng Q, Luo M, Hou Y, Yue J, et al. Human umbilical cord mesenchymal stem cell-derived extracellular vesicles loaded with TFCP2 activate Wnt/β-catenin signaling to alleviate preeclampsia. Int Immunopharmacol. 2023;115:109732 pubmed publisher |
Sch xf6 nborn M, Gregorczyk Maga I, Batko K, Maga M, Bogucka K, Gawlik K, et al. Angiogenic and Microvascular Status Alterations after Endovascular Revascularization of Lower Limb Arteries among Patients with Diabetic Foot Syndrome: A Prospective 12-Month Follow-Up Study. J Clin Med. 2023;12: pubmed publisher |
Komaki R, Miyagaki T, Tanaka M, Nakajima K, Okano T, Takeuchi S, et al. Increased Interleukin-36β Expression Promotes Angiogenesis in Japanese Atopic Dermatitis. Int J Mol Sci. 2023;24: pubmed publisher |
Sch xf6 nborn M, Gregorczyk Maga I, Batko K, Bogucka K, Maga M, P x142 otek A, et al. Circulating Angiogenic Factors and Ischemic Diabetic Foot Syndrome Advancement-A Pilot Study. Biomedicines. 2023;11: pubmed publisher |
Huang X, Jia L, Jia Y, Xu X, Wang R, Wei M, et al. sFlt-1-enriched exosomes induced endothelial cell dysfunction and a preeclampsia-like phenotype in mice. Cytokine. 2023;166:156190 pubmed publisher |
Kurlak L, Scaife P, Briggs L, Broughton Pipkin F, Gardner D, Mistry H. Alterations in Antioxidant Micronutrient Concentrations in Placental Tissue, Maternal Blood and Urine and the Fetal Circulation in Pre-eclampsia. Int J Mol Sci. 2023;24: pubmed publisher |
Dymara Konopka W, Laskowska M, Grywalska E, Hymos A, B x142 a x17c ewicz A, Leszczy x144 ska Gorzelak B. Similar Pro- and Antiangiogenic Profiles Close to Delivery in Different Clinical Presentations of Two Pregnancy Syndromes: Preeclampsia and Fetal Growth Restriction. Int J Mol Sci. 2023;24: pubmed publisher |
Tsai T, Alwees M, Asaad M, Theile J, Kakkassery V, Dick H, et al. Increased Angiopoietin-1 and -2 levels in human vitreous are associated with proliferative diabetic retinopathy. PLoS ONE. 2023;18:e0280488 pubmed publisher |
Darmochwal Kolarz D, Chara A. The Association of IL-17 and PlGF/sENG Ratio in Pre-Eclampsia and Adverse Pregnancy Outcomes. Int J Environ Res Public Health. 2022;20: pubmed publisher |
Klaassen I, Avery P, Schlingemann R, Steel D. Vitreous protein networks around ANG2 and VEGF in proliferative diabetic retinopathy and the differential effects of aflibercept versus bevacizumab pre-treatment. Sci Rep. 2022;12:21062 pubmed publisher |
Kuriyama S, Yamada T, Matsuda A, Takahashi G, Iwai T, Takeda K, et al. Biomarkers for anti-vascular endothelial growth factor drugs. Oncol Lett. 2022;24:463 pubmed publisher |
Anto E, Coall D, Asiamah E, Afriyie O, Addai Mensah O, Wiafe Y, et al. Placental lesions and differential expression of pro-and anti-angiogenic growth mediators and oxidative DNA damage marker in placentae of Ghanaian suboptimal and optimal health status pregnant women who later developed preeclampsia. PLoS ONE. 2022;17:e0265717 pubmed publisher |
Wada H, Shinozaki T, Suzuki M, Sakagami S, Ajiro Y, Funada J, et al. Impact of Chronic Kidney Disease on the Associations of Cardiovascular Biomarkers With Adverse Outcomes in Patients With Suspected or Known Coronary Artery Disease: The EXCEED-J Study. J Am Heart Assoc. 2022;11:e023464 pubmed publisher |
Yagi K, Mimura K, Tomimatsu T, Matsuyama T, Kawanishi Y, Kakigano A, et al. Potency of Tokishakuyakusan in treating preeclampsia: Drug repositioning method by in vitro screening of the Kampo library. PLoS ONE. 2020;15:e0244684 pubmed publisher |
Parchem J, Kanasaki K, Lee S, Kanasaki M, Yang J, Xu Y, et al. STOX1 deficiency is associated with renin-mediated gestational hypertension and placental defects. JCI Insight. 2021;6: pubmed publisher |
Kim S, Park M, Kim J, Kim T, Hwang J, Ha K, et al. Circulating miRNAs Associated with Dysregulated Vascular and Trophoblast Function as Target-Based Diagnostic Biomarkers for Preeclampsia. Cells. 2020;9: pubmed publisher |
Wilson D, Howard M, Fung A, O Donoghue F, Barnes M, Lappas M, et al. Sleep-disordered breathing does not impact maternal outcomes in women with hypertensive disorders of pregnancy. PLoS ONE. 2020;15:e0232287 pubmed publisher |
Nikuei P, Rajaei M, Roozbeh N, Mohseni F, Poordarvishi F, Azad M, et al. Diagnostic accuracy of sFlt1/PlGF ratio as a marker for preeclampsia. BMC Pregnancy Childbirth. 2020;20:80 pubmed publisher |
Jiao W, Ji J, Xu W, Bu W, Zheng Y, Ma A, et al. Distinct downstream signaling and the roles of VEGF and PlGF in high glucose-mediated injuries of human retinal endothelial cells in culture. Sci Rep. 2019;9:15339 pubmed publisher |
Unger H, Hansa A, Buffet C, Hasang W, Teo A, Randall L, et al. Sulphadoxine-pyrimethamine plus azithromycin may improve birth outcomes through impacts on inflammation and placental angiogenesis independent of malarial infection. Sci Rep. 2019;9:2260 pubmed publisher |
Nakada Y, Kawakami R, Matsui M, Ueda T, Nakano T, Nakagawa H, et al. Value of Placental Growth Factor as a Predictor of Adverse Events During the Acute Phase of Acute Decompensated Heart Failure. Circ J. 2019;83:395-400 pubmed publisher |
Tsai T, Kuehn S, Tsiampalis N, Vu M, Kakkassery V, Stute G, et al. Anti-inflammatory cytokine and angiogenic factors levels in vitreous samples of diabetic retinopathy patients. PLoS ONE. 2018;13:e0194603 pubmed publisher |
Perrotta M, Lori A, Carnevale L, Fardella S, Cifelli G, Iacobucci R, et al. Deoxycorticosterone acetate-salt hypertension activates placental growth factor in the spleen to couple sympathetic drive and immune system activation. Cardiovasc Res. 2018;114:456-467 pubmed publisher |
Lamm K, Johnson M, Baker Phillips J, Muntifering M, JAMES J, Jones H, et al. Inverted formin 2 regulates intracellular trafficking, placentation, and pregnancy outcome. elife. 2018;7: pubmed publisher |
O Brien M, Baczyk D, Kingdom J. Endothelial Dysfunction in Severe Preeclampsia is Mediated by Soluble Factors, Rather than Extracellular Vesicles. Sci Rep. 2017;7:5887 pubmed publisher |
Dutta A, Brito K, Khramstova G, Mueller A, Chinthala S, Alexander D, et al. Household air pollution and angiogenic factors in pregnant Nigerian women: A randomized controlled ethanol cookstove intervention. Sci Total Environ. 2017;599-600:2175-2181 pubmed publisher |
Li X, Yao Q, Liu H, Jin Q, Xu B, Zhang S, et al. Placental growth factor silencing ameliorates liver fibrosis and angiogenesis and inhibits activation of hepatic stellate cells in a murine model of chronic liver disease. J Cell Mol Med. 2017;21:2370-2385 pubmed publisher |
Senapati S, Sammel M, Butts S, Takacs P, Chung K, Barnhart K. Predicting first trimester pregnancy outcome: derivation of a multiple marker test. Fertil Steril. 2016;106:1725-1732.e3 pubmed publisher |
Wu D, Lai T, Yuan Y, Chen M, Xia J, Li W, et al. Elevated expression of placental growth factor is associated with airway-wall vascular remodelling and thickening in smokers with asthma. Sci Rep. 2017;7:43017 pubmed publisher |
Jammalamadaga V, Abraham P. Spectrum of Factors Triggering Endothelial Dysfunction in PIH. J Clin Diagn Res. 2016;10:BC14-BC17 pubmed publisher |
Weel I, Baergen R, Romão Veiga M, Borges V, Ribeiro V, Witkin S, et al. Association between Placental Lesions, Cytokines and Angiogenic Factors in Pregnant Women with Preeclampsia. PLoS ONE. 2016;11:e0157584 pubmed publisher |
Dauwe D, Pelacho B, Wibowo A, Walravens A, Verdonck K, Gillijns H, et al. Neovascularization Potential of Blood Outgrowth Endothelial Cells From Patients With Stable Ischemic Heart Failure Is Preserved. J Am Heart Assoc. 2016;5:e002288 pubmed publisher |
Bessho H, Wong B, Huang D, Siew E, Huang D, Tan J, et al. Inhibition of placental growth factor in renal cell carcinoma. Anticancer Res. 2015;35:531-41 pubmed |
Hou H, Cheng S, Chung K, Kuo M, Yeh C, Chang B, et al. Elastase induces lung epithelial cell autophagy through placental growth factor: a new insight of emphysema pathogenesis. Autophagy. 2014;10:1509-21 pubmed publisher |
Calcaterra F, Taddeo A, Colombo E, Cappelletti M, Martinelli A, Calabrese S, et al. Reduction of maternal circulating endothelial progenitor cells in human pregnancies with intrauterine growth restriction. Placenta. 2014;35:431-6 pubmed publisher |
White W, Garrett A, Craici I, Wagner S, Fitz Gibbon P, Butters K, et al. Persistent urinary podocyte loss following preeclampsia may reflect subclinical renal injury. PLoS ONE. 2014;9:e92693 pubmed publisher |
Liu L, Yang T, Ji J, Wen Q, Morgan A, Jin B, et al. Integrating multiple 'omics' analyses identifies serological protein biomarkers for preeclampsia. BMC Med. 2013;11:236 pubmed publisher |
El Tarhouny S, Almasry S, Elfayomy A, Baghdadi H, Habib F. Placental growth factor and soluble Fms-like tyrosine kinase 1 in diabetic pregnancy: A possible relation to distal villous immaturity. Histol Histopathol. 2014;29:259-72 pubmed publisher |
Huang Q, Wang S, Zhang M, Huang L, Tian J, Yu Y, et al. Advanced oxidation protein products enhances soluble Fms-like tyrosine kinase 1 expression in trophoblasts: a possible link between oxidative stress and preeclampsia. Placenta. 2013;34:949-52 pubmed publisher |
Chaturvedi P, Gilkes D, Wong C, Luo W, Zhang H, Wei H, et al. Hypoxia-inducible factor-dependent breast cancer-mesenchymal stem cell bidirectional signaling promotes metastasis. J Clin Invest. 2013;123:189-205 pubmed publisher |
Sleijfer S, Gorlia T, Lamers C, Burger H, Blay J, Le Cesne A, et al. Cytokine and angiogenic factors associated with efficacy and toxicity of pazopanib in advanced soft-tissue sarcoma: an EORTC-STBSG study. Br J Cancer. 2012;107:639-45 pubmed publisher |
Yamashita Kashima Y, Fujimoto Ouchi K, Yorozu K, Kurasawa M, Yanagisawa M, Yasuno H, et al. Biomarkers for antitumor activity of bevacizumab in gastric cancer models. BMC Cancer. 2012;12:37 pubmed publisher |
Rahbari N, Schmidt T, Falk C, Hinz U, Herber M, Bork U, et al. Expression and prognostic value of circulating angiogenic cytokines in pancreatic cancer. BMC Cancer. 2011;11:286 pubmed publisher |
DuBois S, Shusterman S, Ingle A, Ahern C, Reid J, Wu B, et al. Phase I and pharmacokinetic study of sunitinib in pediatric patients with refractory solid tumors: a children's oncology group study. Clin Cancer Res. 2011;17:5113-22 pubmed publisher |
de Groot J, Piao Y, Tran H, Gilbert M, Wu H, Liu J, et al. Myeloid biomarkers associated with glioblastoma response to anti-VEGF therapy with aflibercept. Clin Cancer Res. 2011;17:4872-81 pubmed publisher |
Loupakis F, Cremolini C, Fioravanti A, Orlandi P, Salvatore L, Masi G, et al. Pharmacodynamic and pharmacogenetic angiogenesis-related markers of first-line FOLFOXIRI plus bevacizumab schedule in metastatic colorectal cancer. Br J Cancer. 2011;104:1262-9 pubmed publisher |
Horne A, Shaw J, Murdoch A, McDonald S, Williams A, Jabbour H, et al. Placental growth factor: a promising diagnostic biomarker for tubal ectopic pregnancy. J Clin Endocrinol Metab. 2011;96:E104-8 pubmed publisher |
Jeyabalan A, Powers R, Clifton R, Van Dorsten P, Hauth J, Klebanoff M, et al. Effect of smoking on circulating angiogenic factors in high risk pregnancies. PLoS ONE. 2010;5:e13270 pubmed publisher |
Brave S, Eberlein C, Shibuya M, Wedge S, Barry S. Placental growth factor neutralising antibodies give limited anti-angiogenic effects in an in vitro organotypic angiogenesis model. Angiogenesis. 2010;13:337-47 pubmed publisher |
Powers R, Jeyabalan A, Clifton R, Van Dorsten P, Hauth J, Klebanoff M, et al. Soluble fms-Like tyrosine kinase 1 (sFlt1), endoglin and placental growth factor (PlGF) in preeclampsia among high risk pregnancies. PLoS ONE. 2010;5:e13263 pubmed publisher |
Jaffe I, Newfell B, Aronovitz M, Mohammad N, McGraw A, Perreault R, et al. Placental growth factor mediates aldosterone-dependent vascular injury in mice. J Clin Invest. 2010;120:3891-900 pubmed publisher |
Ha C, Wu J, Irmak S, Lisboa F, Dizon A, Warren J, et al. Human pregnancy specific beta-1-glycoprotein 1 (PSG1) has a potential role in placental vascular morphogenesis. Biol Reprod. 2010;83:27-35 pubmed publisher |
Brittain J, Hulkower B, Jones S, Strayhorn D, De Castro L, Telen M, et al. Placenta growth factor in sickle cell disease: association with hemolysis and inflammation. Blood. 2010;115:2014-20 pubmed publisher |
Verlohren S, Galindo A, Schlembach D, Zeisler H, Herraiz I, Moertl M, et al. An automated method for the determination of the sFlt-1/PIGF ratio in the assessment of preeclampsia. Am J Obstet Gynecol. 2010;202:161.e1-161.e11 pubmed publisher |
Cassidy A, Chiuve S, Manson J, Rexrode K, Girman C, Rimm E. Potential role for plasma placental growth factor in predicting coronary heart disease risk in women. Arterioscler Thromb Vasc Biol. 2009;29:134-9 pubmed publisher |
Rini B, Michaelson M, Rosenberg J, Bukowski R, Sosman J, Stadler W, et al. Antitumor activity and biomarker analysis of sunitinib in patients with bevacizumab-refractory metastatic renal cell carcinoma. J Clin Oncol. 2008;26:3743-8 pubmed publisher |
FINDLEY C, Mitchell R, Duscha B, Annex B, Kontos C. Plasma levels of soluble Tie2 and vascular endothelial growth factor distinguish critical limb ischemia from intermittent claudication in patients with peripheral arterial disease. J Am Coll Cardiol. 2008;52:387-93 pubmed publisher |
Manaster I, Mizrahi S, Goldman Wohl D, Sela H, Stern Ginossar N, Lankry D, et al. Endometrial NK cells are special immature cells that await pregnancy. J Immunol. 2008;181:1869-76 pubmed |
Jeyabalan A, Powers R, Durica A, Harger G, Roberts J, Ness R. Cigarette smoke exposure and angiogenic factors in pregnancy and preeclampsia. Am J Hypertens. 2008;21:943-7 pubmed publisher |
Sorrentino A, Ferracin M, Castelli G, Biffoni M, Tomaselli G, Baiocchi M, et al. Isolation and characterization of CD146+ multipotent mesenchymal stromal cells. Exp Hematol. 2008;36:1035-46 pubmed publisher |
Gutman G, Barak V, Maslovitz S, Amit A, Lessing J, Geva E. Regulation of vascular endothelial growth factor-A and its soluble receptor sFlt-1 by luteinizing hormone in vivo: implication for ovarian follicle angiogenesis. Fertil Steril. 2008;89:922-6 pubmed publisher |
Kissel C, Lehmann R, Assmus B, Aicher A, Honold J, Fischer Rasokat U, et al. Selective functional exhaustion of hematopoietic progenitor cells in the bone marrow of patients with postinfarction heart failure. J Am Coll Cardiol. 2007;49:2341-9 pubmed |
Apple F, Pearce L, Chung A, Ler R, Murakami M. Multiple biomarker use for detection of adverse events in patients presenting with symptoms suggestive of acute coronary syndrome. Clin Chem. 2007;53:874-81 pubmed |
Cianfarani F, Zambruno G, Brogelli L, Sera F, Lacal P, Pesce M, et al. Placenta growth factor in diabetic wound healing: altered expression and therapeutic potential. Am J Pathol. 2006;169:1167-82 pubmed |
Levine R, Lam C, Qian C, Yu K, Maynard S, Sachs B, et al. Soluble endoglin and other circulating antiangiogenic factors in preeclampsia. N Engl J Med. 2006;355:992-1005 pubmed |
Wallner W, Sengenberger R, Strick R, Strissel P, Meurer B, Beckmann M, et al. Angiogenic growth factors in maternal and fetal serum in pregnancies complicated by intrauterine growth restriction. Clin Sci (Lond). 2007;112:51-7 pubmed |
Iwama H, Uemura S, Naya N, Imagawa K, Takemoto Y, Asai O, et al. Cardiac expression of placental growth factor predicts the improvement of chronic phase left ventricular function in patients with acute myocardial infarction. J Am Coll Cardiol. 2006;47:1559-67 pubmed |
Moreno M, Ball M, Andrade M, McDermid A, Stanimirovic D. Insulin-like growth factor binding protein-4 (IGFBP-4) is a novel anti-angiogenic and anti-tumorigenic mediator secreted by dibutyryl cyclic AMP (dB-cAMP)-differentiated glioblastoma cells. Glia. 2006;53:845-57 pubmed |
Briguori C, Testa U, Colombo A, Petrucci E, Condorelli G, Airoldi F, et al. Relation of various plasma growth factor levels in patients with stable angina pectoris and total occlusion of a coronary artery to the degree of coronary collaterals. Am J Cardiol. 2006;97:472-6 pubmed |
Masuyama H, Suwaki N, Nakatsukasa H, Masumoto A, Tateishi Y, Hiramatrsu Y. Circulating angiogenic factors in preeclampsia, gestational proteinuria, and preeclampsia superimposed on chronic glomerulonephritis. Am J Obstet Gynecol. 2006;194:551-6 pubmed |
Buhimschi C, Norwitz E, Funai E, Richman S, Guller S, Lockwood C, et al. Urinary angiogenic factors cluster hypertensive disorders and identify women with severe preeclampsia. Am J Obstet Gynecol. 2005;192:734-41 pubmed |
Levine R, Thadhani R, Qian C, Lam C, Lim K, Yu K, et al. Urinary placental growth factor and risk of preeclampsia. JAMA. 2005;293:77-85 pubmed |
Nishishita T, Ouchi K, Zhang X, Inoue M, Inazawa T, Yoshiura K, et al. A potential pro-angiogenic cell therapy with human placenta-derived mesenchymal cells. Biochem Biophys Res Commun. 2004;325:24-31 pubmed |
Levine R, Maynard S, Qian C, Lim K, England L, Yu K, et al. Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med. 2004;350:672-83 pubmed |
Tsao P, Su Y, Li H, Huang P, Chien C, Lai Y, et al. Overexpression of placenta growth factor contributes to the pathogenesis of pulmonary emphysema. Am J Respir Crit Care Med. 2004;169:505-11 pubmed |
Maynard S, Min J, Merchan J, Lim K, Li J, Mondal S, et al. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest. 2003;111:649-58 pubmed |
Oura H, Bertoncini J, Velasco P, Brown L, Carmeliet P, Detmar M. A critical role of placental growth factor in the induction of inflammation and edema formation. Blood. 2003;101:560-7 pubmed |
Chappell L, Seed P, Briley A, Kelly F, Hunt B, Charnock Jones D, et al. A longitudinal study of biochemical variables in women at risk of preeclampsia. Am J Obstet Gynecol. 2002;187:127-36 pubmed |
Zhou Y, McMaster M, Woo K, Janatpour M, Perry J, Karpanen T, et al. Vascular endothelial growth factor ligands and receptors that regulate human cytotrophoblast survival are dysregulated in severe preeclampsia and hemolysis, elevated liver enzymes, and low platelets syndrome. Am J Pathol. 2002;160:1405-23 pubmed |
